Read + Share
Gu Z, Wang L, Dong Q, Xu K, et al. Aberrant LYZ expression in tumor cells serves as the potential biomarker and
target for HCC and promotes tumor progression via csGRP78. Proc Natl Acad Sci U S A 2023;120:e2215744120.
PMID: 37428911
|
 |
|
Gu Z, Wang L, Dong Q, Xu K, et al. Aberrant LYZ expression in tumor cells serves as the potential biomarker and
target for HCC and promotes tumor progression via csGRP78. Proc Natl Acad Sci U S A 2023;120:e2215744120.
PMID: 37428911
|
|
|
|